Amanida: an R package for meta-analysis of metabolomics non-integral data

Abstract Summary The combination, analysis and evaluation of different studies which try to answer or solve the same scientific question, also known as a meta-analysis, plays a crucial role in answering relevant clinical relevant questions. Unfortunately, metabolomics studies rarely disclose all the statistical information needed to perform a meta-analysis. Here, we present a meta-analysis approach using only the most reported statistical parameters in this field: P-value and fold-change. The P-values are combined via Fisher’s method and fold-changes by averaging, both weighted by the study size (n). The amanida package includes several visualization options: a volcano plot for quantitative results, a vote plot for total regulation behaviours (up/down regulations) for each compound, and a explore plot of the vote-counting results with the number of times a compound is found upregulated or downregulated. In this way, it is very easy to detect discrepancies between studies at a first glance. Availability and implementation Amanida code and documentation are at CRAN and https://github.com/mariallr/amanida. Supplementary information Supplementary data are available at Bioinformatics online.

[1]  Stefan Mutter,et al.  Statistical reporting of metabolomics data: experience from a high-throughput NMR platform and epidemiological applications , 2019, Metabolomics.

[2]  Claire O'Donovan,et al.  MetaboLights: a resource evolving in response to the needs of its scientific community , 2019, Nucleic Acids Res..

[3]  Yongseok Park,et al.  P-value evaluation, variability index and biomarker categorization for adaptively weighted Fisher's meta-analysis method in omics applications , 2017, Bioinform..

[4]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[5]  T. Park,et al.  Powerful p-value combination methods to detect incomplete association , 2021, Scientific Reports.

[6]  Gerta Rücker,et al.  How to perform a meta-analysis with R: a practical tutorial , 2019, Evidence-Based Mental Health.

[7]  Caroline H. Johnson,et al.  Beyond genomics: understanding exposotypes through metabolomics , 2018, Human Genomics.

[8]  Jordi Oliver,et al.  Breast and lung cancer are associated with a decrease in blood cell amino acid content. , 2003, The Journal of nutritional biochemistry.

[9]  M. Kendall Statistical Methods for Research Workers , 1937, Nature.

[10]  J. Brezmes,et al.  Comprehensive Volatilome and Metabolome Signatures of Colorectal Cancer in Urine: A Systematic Review and Meta-Analysis , 2021, Cancers.

[11]  A. Moser,et al.  Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics , 2020, Metabolites.

[12]  Douglas Curran-Everett,et al.  Explorations in statistics: the log transformation. , 2018, Advances in physiology education.

[13]  David S. Wishart,et al.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..

[14]  W. Seow,et al.  Association between Metabolites and the Risk of Lung Cancer: A Systematic Literature Review and Meta-Analysis of Observational Studies , 2020, Metabolites.

[15]  Rui Zhang,et al.  Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites. , 2018, Journal of chromatography. A.

[16]  Nigel W. Hardy,et al.  Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.

[17]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[18]  E. Dudley,et al.  Metabolomics and Biomarker Discovery. , 2019, Advances in experimental medicine and biology.

[19]  T. Ahluwalia,et al.  Plasma metabolomics identifies markers of impaired renal function: A meta-analysis of 3,089 persons with type 2 diabetes. , 2020, The Journal of clinical endocrinology and metabolism.

[20]  Alexei Vazquez,et al.  Stratification of cancer and diabetes based on circulating levels of formate and glucose , 2019, Cancer & metabolism.

[21]  Jean-Louis Foulley,et al.  Gene expression Moderated effect size and P-value combinations for microarray meta-analyses , 2009 .

[22]  J. Xia,et al.  Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets , 2021, Metabolites.

[23]  Pim E G Leonards,et al.  Use cases, best practice and reporting standards for metabolomics in regulatory toxicology , 2019, Nature Communications.